Keryx Biopharmaceuticals (KERX) Announces Appointment of Daniel P. Regan to Board of Directors
10/4/2013 9:19:11 AM
NEW YORK, 2013-10-04 14:30 CEST (GLOBE NEWSWIRE) --
Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the appointment of
Daniel P. Regan to the Company's Board of Directors.
Daniel P. Regan, 49, joins the Keryx Board of Directors with broad
pharmaceutical leadership experience across the spectrum of global
commercialization, sales and marketing of novel therapies for the treatment of
patients with chronic kidney disease.
Help employers find you! Check out all the jobs and post your resume.
comments powered by